Matches in Nanopublications for { ?s ?p "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP631815.RAXWoNuwCYKmOM3Cq3Z-iLOJsgaRuvaCYYkHvJXe7kb6g130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631815.RAXWoNuwCYKmOM3Cq3Z-iLOJsgaRuvaCYYkHvJXe7kb6g130_provenance.
- NP773874.RAUpC32xhnBSRVxFXcZ--wLu2M_QViqyhEtp6L92C-2go130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773874.RAUpC32xhnBSRVxFXcZ--wLu2M_QViqyhEtp6L92C-2go130_provenance.
- NP684541.RAse5B8mjfcwZXktq8GOB4EYKAWZfacjRLHTSSE80k2qs130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684541.RAse5B8mjfcwZXktq8GOB4EYKAWZfacjRLHTSSE80k2qs130_provenance.
- NP710114.RArj_HEVqiEAPt7jDhmmy5Y4swVl-OoTyaHqepMHaJLvs130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710114.RArj_HEVqiEAPt7jDhmmy5Y4swVl-OoTyaHqepMHaJLvs130_provenance.
- NP437747.RA7bVZE0Lyl0q-U3h1MVM9S_hirRaVPDY1gynC__2QYOo130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437747.RA7bVZE0Lyl0q-U3h1MVM9S_hirRaVPDY1gynC__2QYOo130_provenance.
- NP401414.RACW3C-VQkRWDiitCAGWhdDuCgboWPZQoqR109XszXxIo130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401414.RACW3C-VQkRWDiitCAGWhdDuCgboWPZQoqR109XszXxIo130_provenance.
- assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP682954.RA4DKblEAODm-_vxGec4Adi_lXnCZ_FoUjFq2s0W1Pxzk130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682954.RA4DKblEAODm-_vxGec4Adi_lXnCZ_FoUjFq2s0W1Pxzk130_provenance.
- NP401898.RAKjNJoHu9M52yvCk2jFjzTdVk85JbzpWcxWQVbdCrWfU130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401898.RAKjNJoHu9M52yvCk2jFjzTdVk85JbzpWcxWQVbdCrWfU130_provenance.
- NP682952.RAVShN1RU6GKsXQhT2SRdL_kNuq_Nd0e_V3OoSvux6aqo130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682952.RAVShN1RU6GKsXQhT2SRdL_kNuq_Nd0e_V3OoSvux6aqo130_provenance.
- NP682955.RAORn1czWkYOxLpMjuzt850isWrMpeHk38lglktrHf5hU130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682955.RAORn1czWkYOxLpMjuzt850isWrMpeHk38lglktrHf5hU130_provenance.
- NP682956.RAleDV3bdx89B5naAOxHBhz6jntkjIIRfyFaaZZ7jWiIs130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682956.RAleDV3bdx89B5naAOxHBhz6jntkjIIRfyFaaZZ7jWiIs130_provenance.
- NP682958.RAuVRHmBzJS7-QU4h-zY36RuK9nA6oUYJWTGv6JHCHdAc130_assertion description "[Gene amplification or missense mutation of FGFR2 occurs in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682958.RAuVRHmBzJS7-QU4h-zY36RuK9nA6oUYJWTGv6JHCHdAc130_provenance.